+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Advanced Balloon Catheter Market: Analysis and Forecast, 2021-2030

  • ID: 5188174
  • Report
  • November 2020
  • Region: Global
  • 283 Pages
  • BIS Research

Enquire about COVID-19 updates for this product.

Enquire Now
Global Advanced Balloon Catheter Market to Reach $4,405.3 Million by 2030

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik AG
  • Cardionovum GmbH
  • Cook Group
  • Koninklijke Philips N.V.
  • OrbusNeich Medical
  • MORE

Market Report Coverage - Advanced Balloon Catheter

Market Segmentation

  • Product Type - Normal Balloon Catheter, Cutting and Scoring balloon catheter, Drug-Coated balloon catheter, and Stent Graft balloon catheter
  • Application - Coronary procedures, Peripheral procedures, Neurovascular procedures, and Others
  • Component - Over the Wire balloon catheter, Rapid Exchange balloon catheter, and Fixed-Wire balloon catheter
  • Patient age - Adult and Pediatric
  • End-User - Hospitals and Ambulatory Surgery Centers, Catherization Laboratories, and Others

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Rest-of-Europe
  • Asia-Pacific - China, Japan, India, South Korea, Singapore, Australia and New Zealand, Rest-of-Asia-Pacific
  • Latin America - Brazil, Mexico, and Rest of Latin America
  • Middle East and Africa

Growth Drivers

  • Increasing prevalence of cardiovascular and peripheral artery disease
  • Increasing demand for minimally invasive surgery
  • Advancement in balloon catheter
  • Favorable reimbursement landscape in developed economies

Market Challenges

  • High cost of angioplasty
  • Risk and complication associated with catheterization procedures

Market Opportunities

  • Development of novel drug-coated balloon catheter
  • Development of multipurpose balloon catheter

Global Advanced Balloon Catheter Market: Analysis and Forecast, 2021-2030

Key Companies Profiled

Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Koninklijke Philips N.V., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, Biotronik AG, Cardionovum GmbH, Concept Medical Inc., Cook Group, Hexacath, and OrbusNeich Medical

Key Questions Answered in this Report:

  • How has the COVID-19 pandemic impacted the global advanced balloon catheter market?
  • What is the adoption rate of the balloon catheters in peripheral artery disease (PAD) and coronary artery disease (CAD) across various regions?
  • What is the reimbursement landscape for the balloon catheters across various regions?
  • How does the regulatory landscape for the balloon catheters impact the overall global advanced balloon catheter market?
  • Who are the key players in the global advanced balloon catheters and their respective market share?
  • What are the key strategies employed by the companies for entering the market between 2016-June 2020?
  • What is the patent landscape for the global advanced balloon catheter market? Who are the major market players that have filed for patents between January 2017- August 2020?
  • How will the entry of products that are in the pipeline till mid-September 2020 impact the global advanced balloon catheter market during the forecast period 2021-2030?
  • What are the various types of balloon catheters available in the global advanced balloon catheter market? What is their market share in 2019 and 2030, respectively?
  • Which type of balloon catheter is anticipated to witness the growth with the highest compound annual growth rate (CAGR) during the forecast period 2021-2030?
  • What are the emerging applications for the balloon catheters?
  • What are the various components of balloon catheters? Which type of balloon catheter is anticipated to witness significant growth during the forecast period 2021-2030?
  • How is the global advanced balloon catheter market anticipated to grow in the emerging economies, such as Asia-Pacific, Latin America, Middle East, and Africa?

Market Overview

The global advanced balloon catheter market is witnessing a moderate decline in the size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $2,523.9 million in FY2019, and it is expected to grow at a CAGR of 6.25% during the forecast period, 2021-2030. Presently, more than 70 companies are operating in this market, including already existing and emerging medical device companies.

Owing to the COVID-19 pandemic, the global elective surgeries were shutdown, which, in turn, caused the decline of the global advanced balloon catheter market in 2020. However, the impact of the pandemic is anticipated to be short-term, and with the resumption of elective procedures, the global advanced balloon catheter market is projected to recover from 2021.

Our healthcare experts are continuously analyzing the impact of the industrial and regulatory decisions on the global advanced balloon catheter market. The market is driven by certain factors, increasing prevalence of cardiovascular and peripheral artery diseases, increasing demand for minimally invasive surgeries, advancements in the balloon catheters, and favorable reimbursement landscape in developed economies.

The market is favored by the development of novel drug-coated balloon catheter and multipurpose balloon catheter.

Within the research report, the market is segmented based on product type, component, application, patient age, end-user, and regional analysis. Each of these segments covers the market’s snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik AG
  • Cardionovum GmbH
  • Cook Group
  • Koninklijke Philips N.V.
  • OrbusNeich Medical
  • MORE

1 Product Definition

2 Scope of Report
2.1 Scope of Study
2.2 Exclusion Criteria of the Report
2.3 Key Questions Answered by the Research Study

3 Research Methodology
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Data Sources Categorization
3.4 Selection Criteria for Company Profiles
3.5 Brief Overview of the Market Estimation Process
3.6 Data Validation
3.7 Assumptions and Limitations

4 Impact of COVID-19 on Global Advanced Balloon Catheter Market
4.1 Impact on Patients
4.2 Impact on Adoption Rate of Advanced Balloon Catheters
4.3 Impact on the Growth Rate of the Global Advanced Balloon Catheter Market
4.4 Entry Barriers and Opportunities for Companies Entering Global Advanced Balloon Catheter Market

5 Epidemiology and Reimbursement Landscape for Global Advanced Balloon Catheter Market
5.1 Utilization of Balloon Catheters
5.1.1 Coronary Procedures
5.1.2 Peripheral Procedures
5.2 Reimbursement Landscape
5.2.1 The U.S.
5.2.2 Europe

6 Industry Analysis
6.1 Industry Structure
6.1.1 Balloon Catheters Manufacturers
6.1.2 Distributors
6.2 Industry Supply Chain Analysis
6.2.1 Raw Material
6.2.2 Impact of COVID-19 on Supply Chain
6.3 Associations and Consortiums
6.4 Regulatory Framework
6.4.1 Regulatory Framework in North America
6.4.1.1 Food and Drug Administration (FDA)
6.4.1.2 Health Canada
6.4.2 Regulatory Framework in Europe
6.4.3 Regulatory Framework in Asia-Pacific
6.4.3.1 National Medical Products Administration (NMPA)
6.4.3.2 Pharmaceutical and Medical Device Agency (PMDA)
6.4.3.3 Central Drug Standard Control Organization (CDSCO)
6.5 Patent Analysis
6.5.1 Patent Analysis (by Product)
6.5.2 Patent Analysis (by Country)

7 Competitive Landscape
7.1 Market Share Analysis
7.2 Key Developments and Strategies
7.2.1 Regulatory and Legal
7.2.2 Mergers and Acquisitions
7.2.3 Partnerships, Alliances, and Business Expansions
7.2.4 New Offerings
7.2.5 Funding Activities
7.3 Product Pipeline Analysis
7.4 Comparison Between Conventional Balloon Catheters and Advanced Balloon Catheters
7.5 Pricing Analysis

8 Global Advanced Balloon Catheter Market Sizing and Forecast
8.1 Assumptions and Limitations
8.2 Key Findings and Opportunity Assessment
8.2.1 Key Findings
8.2.2 Opportunity Assessment
8.3 Market Dynamics
8.3.1 Market Drivers
8.3.1.1 Increasing Prevalence of Cardiovascular and Peripheral Artery Diseases
8.3.1.2 Increasing Demand for Minimally Invasive Surgeries
8.3.1.3 Advancements in Balloon Catheters
8.3.1.4 Favorable Reimbursement Landscape in Developed Economies
8.3.2 Market Restraints
8.3.2.1 Risk and Complications Associated with Catherization Procedures
8.3.2.2 High Cost of Angioplasty Procedures
8.3.3 Impact Analysis
8.3.4 Market Opportunities
8.3.4.1 Development of Novel Drug-Coated Balloon Catheters
8.3.4.2 Development of Multipurpose Advanced Balloon Catheter

9 Global Advanced Balloon Catheter Market (by Product Type)
9.1 Overview
9.2 Normal Balloon Catheter
9.3 Cutting and Scoring Balloon Catheter
9.4 Drug-Coated Balloon Catheter
9.5 Stent Graft Balloon Catheter

10 Global Advanced Balloon Catheter Market (by Application)
10.1 Overview
10.2 Coronary Procedures
10.3 Peripheral Procedures
10.4 Neurovascular Procedures
10.5 Other Procedures

11 Global Advanced Balloon Catheter Market (by Component)
11.1 Overview
11.2 Rapid Exchange (Rx) Balloon Catheter
11.3 Over the Wire (OTW) Balloon Catheter
11.4 Fixed Wire Balloon Catheter

12 Global Advanced Balloon Catheter Market (by Patient Age)
12.1 Overview
12.2 Adult
12.3 Pediatric

13 Global Advanced Balloon Catheter Market (by End User)
13.1 Overview
13.2 Hospitals and Ambulatory Surgery Centers
13.3 Catheterization Laboratories
13.4 Others

14 Global Advanced Balloon Catheter Market (by Region)
14.1 North America Advanced Balloon Catheter Market
14.1.1 North America Advanced Balloon Catheter Market (by Product Type)
14.1.2 North America Advanced Balloon Catheter Market (by Application)
14.1.3 North America Advanced Balloon Catheter Market (by Patient Age)
14.1.4 North America Advanced Balloon Catheter Market (by End User)
14.1.5 North America Advanced Balloon Catheter Market (by Country)
14.1.5.1 The U.S.
14.1.5.1.1 The U.S. Advanced Balloon Catheter Market (by End User)
14.1.5.2 Canada
14.1.5.2.1 Canada Advanced Balloon Catheter Market (by End User)
14.2 Europe Advanced Balloon Catheter Market
14.2.1 Europe Advanced Balloon Catheter Market (by Product Type)
14.2.2 Europe Advanced Balloon Catheter Market (by Application)
14.2.3 Europe Advanced Balloon Catheter Market (by Patient Age)
14.2.4 Europe Advanced Balloon Catheter Market (by End User)
14.2.5 Europe Advanced Balloon Catheter Market (by Country)
14.2.5.1 Germany
14.2.5.1.1 Germany Advanced Balloon Catheter Market (by End User)
14.2.5.2 The U.K.
14.2.5.2.1 The U.K. Advanced Balloon Catheter Market (by End User)
14.2.5.3 France
14.2.5.3.1 France Advanced Balloon Catheter Market (by End User)
14.2.5.4 Italy
14.2.5.4.1 Italy Advanced Balloon Catheter Market (by End User)
14.2.5.5 Spain
14.2.5.5.1 Spain Advanced Balloon Catheter Market (by End User)
14.2.5.6 Rest-of-Europe
14.2.5.6.1 Rest-of-Europe Advanced Balloon Catheter Market (by End User)
14.3 Asia-Pacific Advanced Balloon Catheter Market
14.3.1 Asia-Pacific Advanced Balloon Catheter Market (by Product Type)
14.3.2 Asia-Pacific Advanced Balloon Catheter Market (by Application)
14.3.3 Asia-Pacific Advanced Balloon Catheter Market (by Patient Age)
14.3.4 Asia-Pacific Advanced Balloon Catheter Market (by End User)
14.3.5 Asia-Pacific Advanced Balloon Catheter Market (by Country)
14.3.5.1 Japan
14.3.5.1.1 Japan Advanced Balloon Catheter Market (by End User)
14.3.5.2 China
14.3.5.2.1 China Advanced Balloon Catheter Market (by End User)
14.3.5.3 India
14.3.5.3.1 India Advanced Balloon Catheter Market (by End User)
14.3.5.4 South Korea
14.3.5.4.1 South Korea Advanced Balloon Catheter Market (by End User)
14.3.5.5 Australia and New Zealand
14.3.5.5.1 Australia and New Zealand Advanced Balloon Catheter Market (by End User)
14.3.5.6 Singapore
14.3.5.6.1 Singapore Advanced Balloon Catheter Market (by End User)
14.3.5.7 Rest-of-Asia-Pacific
14.3.5.7.1 Rest-of-Asia-Pacific Advanced Balloon Catheter Market (by End User)
14.4 Latin America Advanced Balloon Catheter Market
14.4.1 Latin America Advanced Balloon Catheter Market (by Product Type)
14.4.2 Latin America Advanced Balloon Catheter Market (by Application)
14.4.3 Latin America Advanced Balloon Catheter Market (by Patient Age)
14.4.4 Latin America Advanced Balloon Catheter Market (by End User)
14.4.5 Latin America Advanced Balloon Catheter Market (by Country)
14.4.5.1 Brazil
14.4.5.1.1 Brazil Advanced Balloon Catheter Market (by End User)
14.4.5.2 Mexico
14.4.5.2.1 Mexico Advanced Balloon Catheter Market (by End User)
14.4.5.3 Rest-of-Latin America
14.4.5.3.1 Rest-of-Latin America Advanced Balloon Catheter Market (by End User)
14.5 Middle East and Africa Advanced Balloon Catheter Market
14.5.1 Middle East and Africa Advanced Balloon Catheter Market (by Product Type)
14.5.2 Middle East and Africa Advanced Balloon Catheter Market (by Application)
14.5.3 Middle East and Africa Advanced Balloon Catheter Market (by Patient Age)
14.5.4 Middle East and Africa Advanced Balloon Catheter Market (by End User)

15 Company Profiles
15.1 Abbott Laboratories
15.1.1 Company Overview
15.1.2 Role of Abbott Laboratories in Global Advanced Balloon Catheter Market
15.1.3 Financials
15.1.4 Recent Developments
15.1.5 SWOT Analysis
15.2 B. Braun Melsungen AG
15.2.1 Company Overview
15.2.2 Role of B. Braun Melsungen AG. in Global Advanced Balloon Catheter Market
15.2.3 Financials
15.2.4 Recent Developments
15.2.5 SWOT Analysis
15.3 Becton Dickinson and Company
15.3.1 Company Overview
15.3.2 Role of Becton, Dickinson and Company in Global Advanced Balloon Catheter Market
15.3.3 Financials
15.3.4 Recent Developments
15.3.5 SWOT Analysis
15.4 Biotronik AG
15.4.1 Company Overview
15.4.2 Role of Biotronik AG in Global Advanced Balloon Catheter Market
15.4.3 SWOT Analysis
15.5 Boston Scientific Corporation
15.5.1 Company Overview
15.5.2 Role of Boston Scientific Corporation in the Advanced Balloon Catheter Market
15.5.3 Financials
15.5.4 SWOT Analysis
15.6 Cardinal Health, Inc.
15.6.1 Company Overview
15.6.2 Role of Cardinal Health, Inc. in Global Advanced Balloon Catheter
15.6.3 Financials
15.6.4 Recent Developments
15.6.5 SWOT Analysis
15.7 Cardionovum GmbH
15.7.1 Company Overview
15.7.2 Role of Cardionovum GmbH in Global Advanced Balloon Catheter
15.7.3 Recent Developments
15.7.4 SWOT Analysis
15.8 Concept Medical Inc.
15.8.1 Company Overview
15.8.2 Role of Concept Medical Inc. in Global Advanced Balloon Catheter
15.8.3 Recent Developments
15.8.4 SWOT Analysis
15.9 Cook Group
15.9.1 Company Overview
15.9.2 Role of Cook Group in Global Advanced Balloon Catheter Market
15.9.3 Recent Developments
15.9.4 SWOT Analysis
15.1 Hexacath
15.10.1 Company Overview
15.10.2 Role of Hexacath in Global Advanced Balloon Catheter Market
15.10.3 SWOT Analysis
15.11 Koninklijke Philips N.V.
15.11.1 Company Overview
15.11.2 Role of Koninklijke Philips N.V. in Global Advanced Balloon Catheter Market
15.11.3 Financials
15.11.4 Recent Developments
15.11.5 SWOT Analysis
15.12 Medtronic plc
15.12.1 Company Overview
15.12.2 Role of Medtronic plc in Global Advanced Balloon Catheter Market
15.12.3 Financials
15.12.4 Recent Developments
15.12.5 SWOT Analysis
15.13 MicroPort Scientific Corporation
15.13.1 Company Overview
15.13.2 Role of MicroPort Scientific Corporation in Global Advanced Balloon Catheter Market
15.13.3 Financials
15.13.4 Recent Developments
15.13.5 SWOT Analysis
15.14 OrbusNeich Medical
15.14.1 Company Overview
15.14.2 Role of OrbusNeich Medical in Global Advanced Balloon Catheter Market
15.14.3 Recent Developments
15.14.4 SWOT Analysis
15.15 Terumo Corporation
15.15.1 Company Overview
15.15.2 Role of Terumo Corporation in Global Advanced Balloon Catheter Market
15.15.3 Financials
15.15.4 Recent Developments
15.15.5 SWOT Analysis

List of Tables
Table 5.1: CPT Codes and the Associated Procedures
Table 5.2: U.S. Balloon Angioplasty Reimbursement
Table 5.3: Europe Normal Balloon Angioplasty Reimbursement
Table 5.4: Europe Drug-Coated Balloon Angioplasty Reimbursement
Table 6.1: Balloon Catheter Manufacturers
Table 6.2: Associations/Consortiums of the Global Advanced Balloon Catheter Market
Table 7.1: Global Advanced Balloon Catheter Market: Product Pipeline Analysis
Table 7.2: Average Pricing of Coronary Normal Balloon Catheters
Table 7.3: Average Pricing of Peripheral Normal Balloon Catheters
Table 7.4: Average Pricing of Cutting and Scoring Balloon Catheters
Table 7.5: Average Pricing of Drug-Coated Balloon Catheters
Table 8.1: Advanced Balloon Catheters: Indications and Products
Table 8.2: Cumulative Cost and QALY Analysis of CABG, PCI and Medical Treatment
Table 14.1: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in North America, 2015-2017
Table 14.2: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in the U.S., 2015-2017
Table 14.3: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Canada, 2015-2017
Table 14.4: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Europe, 2015-2017
Table 14.5: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Germany, 2015-2017
Table 14.6: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in the U.K., 2015-2017
Table 14.7: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in France, 2015-2017
Table 14.8: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Italy, 2015-2017
Table 14.9: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Spain, 2015-2017
Table 14.10: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Asia, 2015-2017
Table 14.11: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Japan, 2015-2017
Table 14.12: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in China, 2015-2017
Table 14.13: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in India, 2015-2017
Table 14.14: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in South Korea, 2015-2017
Table 14.15: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Australia and New Zealand, 2015-2017
Table 14.16: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Singapore, 2015-2017
Table 14.17: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Latin America, 2015-2017
Table 14.18: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Brazil, 2015-2017
Table 14.19: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Mexico, 2015-2017
Table 14.20: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Rest-of-Latin America, 2015-2017
Table 14.21: Prevalence of Cardiovascular Disease and Peripheral Artery Disease in Middle East and Africa, 2015-2017

List of Figures
Figure 1: Global Cost Burden Analysis for Diseases
Figure 2: Global Advanced Balloon Catheter Market, Pre-COVID-19, $Million
Figure 3: Post-COVID-19: Global Advanced Balloon Catheter Market
Figure 4: Impact Analysis: Global Advanced Balloon Catheter Market
Figure 5: Global Advanced Balloon Catheter Market: Industry Structure
Figure 6: Market Share Analysis of Global Advanced Balloon Catheter Market (by Company), 2019
Figure 7: Share of Activities in Key Developments, 2016-August 2020
Figure 8: Global Advanced Balloon Catheter Market (by Product Type), 2019 vs. 2030
Figure 9: Global Advanced Balloon Catheter Market (by Patient Age), 2019 vs. 2030
Figure 10: Global Advanced Balloon Catheter Market (by End User), 2019 vs. 2030
Figure 11: Global Advanced Balloon Catheter Market (by Region)
Figure 2.1: Global Advanced Balloon Catheter Market Segmentation
Figure 3.1: Global Advanced Balloon Catheter Market: Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Total Number of Healthcare Company Profiles
Figure 3.5: Assumptions and Limitations
Figure 4.1: COVID-19 Impact on Elective Procedures in Europe
Figure 4.2: Recovery of Global Advanced Balloon Catheter Market in the Post-COVID-19 Scenario
Figure 4.3: Global Advanced Balloon Catheter Market: Entry Barriers and Opportunities
Figure 5.1: Coronary Procedures (by Region), 2010-2019
Figure 5.2: Peripheral Procedures (by Region), 2010-2019
Figure 6.1: Global Advanced Balloon Catheter Market: Supply Chain Analysis
Figure 6.2: FDA 510(k) Approval Timeline
Figure 6.3: Health Canada Class IV-Medical Device Approval Process
Figure 6.4: European Commission Class IV-Medical Device Approval Process
Figure 6.5: National Medical Products Administration Class III-Medical Device Approval Process
Figure 6.6: Pharmaceutical and Medical Devices Agency (PMDA) Class III-Medical Device Approval Process
Figure 6.7: Central Drug Standard Control Organization (CDSCO) Class D-Medical Device Approval Process
Figure 6.8: Patent Segmentation, by Year, Country, and Product
Figure 6.9: Patent Segmentation, (by Product)
Figure 6.10: Patent Segmentation (by Country)
Figure 7.1: Market Share Analysis of Global Advanced Balloon Catheter Market (by Company), 2019
Figure 7.2: Share of Key Developments and Strategies, January 2016-Mid September 2020
Figure 7.3: Regulatory and Legal (by Company), January 2016-April 2020
Figure 7.4: Mergers and Acquisitions(by Company), January 2016- Mid September 2020
Figure 7.5: Partnerships, Alliances, and Business Expansions (by Company), January 2016-Mid-September 2020
Figure 7.6: New Offerings (by Company), January 2016-mid-September 2020
Figure 7.7: Funding Activities (by Company), January 2016-Mid-September 2020
Figure 7.8: Conventional and Advanced Balloon Catheters Market Share, 2019 vs. 2030
Figure 8.1: Increasing Prevalence of Cardiovascular Disease and Peripheral Artery Disease, 2010-2017
Figure 8.2: Global Increase in Transluminal Coronary Angioplasty, 2013-2017
Figure 8.3: Risk and Complications Associated with Catherization Procedures
Figure 8.4: Global Advanced Balloon Catheter Market: Impact Analysis
Figure 9.1: Global Advanced Balloon Catheter Market (by Product Type), 2019 and 2030
Figure 9.2: Global Advanced Balloon Catheter Market (by Normal Balloon Catheter), $Million, 2019-2030
Figure 9.3: Global Advanced Balloon Catheter Market (by Cutting and Scoring Balloon Catheter), $Million, 2019-2030
Figure 9.4: Global Advanced Balloon Catheter Market (by Drug-Coated Balloon Catheter), $Million, 2019-2030
Figure 9.5: Global Advanced Balloon Catheter Market (by Stent-Graft Balloon Catheter), $Million, 2019-2030
Figure 10.1: Global Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
Figure 10.2: Global Coronary Procedure in Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 10.3: Global Advanced Balloon Catheter Market (by Coronary Procedures), $Million, 2019-2030
Figure 10.4: Global Peripheral Procedure in Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 10.5: Global Advanced Balloon Catheter Market (by Peripheral Procedures), $Million, 2019-2030
Figure 10.6: Global Advanced Balloon Catheter Market (by Neurovascular Procedures), $Million, 2019-2030
Figure 10.7: Global Advanced Balloon Catheter Market (by Other Procedures), $Million, 2019-2030
Figure 11.1: Global Advanced Balloon Catheter Market (by Component), $Million, 2019-2030
Figure 11.2: Global Advanced Balloon Catheter Market (by Rapid Exchange Catheter), $Million, 2019-2030
Figure 11.3: Global Advanced Balloon Catheter Market (Over the Wire), $Million, 2019-2030
Figure 11.4: Global Advanced Balloon Catheter Market (Fixed-Wire Catheter), $Million, 2019-2030
Figure 12.1: Global Advanced Balloon Catheter Market (Adult Patient), $Million, 2019-2030
Figure 12.2: Global Advanced Balloon Catheter Market ( Pediatric Patient), $Million, 2019-2030
Figure 13.1: Global Advanced Balloon Catheter Market (by Hospitals and Ambulatory Surgery Centers), $Million, 2019-2030
Figure 13.2: Global Advanced Balloon Catheter Market (Catherization Laboratories), $Million, 2019-2030
Figure 13.3: Global Advanced Balloon Catheter Market (Academic and Research Institutes), $Million, 2019-2030
Figure 14.1: Global Advanced Balloon Catheter Market (by Region), 2019
Figure 14.2: Global Advanced Balloon Catheter Market (by Region), $Million, 2019-2030
Figure 14.3: North America Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.4: North America Coronary Angioplasty Volume (by Balloon Type), 2010-2019
Figure 14.5: North America Peripheral Artery Procedure (by Balloon Type), 2010-2019
Figure 14.6: North America: Market Dynamics
Figure 14.7: North America Advanced Balloon Catheter Market (by Product Type), $Million, 2019-2030
Figure 14.8: North America Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
Figure 14.9: North America Advanced Balloon Catheter Market (by Patient Age), $Million, 2019-2030
Figure 14.10: North America Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.11: North America Advanced Balloon Catheter Market (by Country)
Figure 14.12: U.S. Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.13: U.S. Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.14: Canada Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.15: Canada Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.16: Europe Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.17: Europe Coronary Angioplasty Volume (by Balloon Type), 2010-2019
Figure 14.18: Europe Peripheral Artery Angioplasty Volume (by Balloon Type), 2010-2019
Figure 14.19: Europe: Market Dynamics
Figure 14.20: Europe Advanced Balloon Catheter Market (by Product Type), $Million, 2019-2030
Figure 14.21: Europe Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
Figure 14.22: Europe Advanced Balloon Catheter Market (by Patient Age), $Million, 2019-2030
Figure 14.23: Europe Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.24: Europe Advanced Balloon Catheter Market (by Country)
Figure 14.25: Germany Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.26: Germany Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
Figure 14.27: U.K. Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.28: U.K. Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.29: France Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.30: France Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.31: Italy Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.32: Italy Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
Figure 14.33: Spain Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.34: Spain Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.35: Rest-of-Europe Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.36: Rest-of-Europe Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.37: Asia-Pacific Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.38: Asia-Pacific Coronary Angioplasty (by Balloon Type), 2010-2019
Figure 14.39: Asia-pacific: Market Dynamics
Figure 14.40: Asia-Pacific Advanced Balloon Catheter Market (by Product Type), $Million, 2019-2030
Figure 14.41: Asia-Pacific Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
Figure 14.42: Asia-Pacific Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
Figure 14.43: Asia-Pacific Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.44: Asia-Pacific Advanced Balloon Catheter Market (by Country)
Figure 14.45: Japan Advanced Balloon Catheter Market, $Million, 2021-2030
Figure 14.46: Japan Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.47: China Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.48: China Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
Figure 14.49: India Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.50: India Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.51: South Korea Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.52: South Korea Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.53: Australia and New Zealand Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.54: Australia and New Zealand Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.55: Singapore Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.56: Singapore Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.57: Rest- of-Asia-Pacific Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.58: Rest-of-Asia-Pacific Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.59: Latin America Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.60: Latin America: Market Dynamics
Figure 14.61: Latin America Advanced Balloon Catheter Market, (by Product Type), $Million, 2019-2030
Figure 14.62: Latin America Advanced Balloon Catheter Market, (by Application), $Million, 2019-2030
Figure 14.63: Latin America Advanced Balloon Catheter Market, (by Patient Age), $Million, 2019-2030
Figure 14.64: Latin America Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
Figure 14.65: Latin America Advanced Balloon Catheter Market (by Country), $Million, 2019-2030
Figure 14.66: Brazil Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.67: Brazil Advanced Balloon Catheter Market (by End User), 2019-2030
Figure 14.68: Mexico Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.69: Mexico Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 14.70 Rest-of-Latin America Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.71: Rest-of-Latin America Advanced Balloon Catheter Market, (by End User), $Million, 2019-2030
Figure 14.72: Middle East and Africa Advanced Balloon Catheter Market, $Million, 2019-2030
Figure 14.73: Middle East and Africa: Market Dynamics
Figure 14.74: Middle East and Africa Advanced Balloon Catheter Market (by Product Type), $Million, 2019-2030
Figure 14.75: Middle East and Africa Advanced Balloon Catheter Market (by Application), $Million, 2019-2030
Figure 14.76: Middle East and Africa Advanced Balloon Catheter Market (by Patient Age), $Million, 2019-2030
Figure 14.77: Middle East and Africa Advanced Balloon Catheter Market (by End User), $Million, 2019-2030
Figure 15.1: Abbott Laboratories: Overall Product Portfolio
Figure 15.2: Abbott Laboratories: Overall Financials, 2017-2019
Figure 15.3: Abbott Laboratories: Revenue (by Business Segment), 2017-2019
Figure 15.4: Abbott Laboratories: Revenue (by Region), 2017-2019
Figure 15.5: Abbott Laboratories.: R&D Expense, 2017-2019
Figure 15.6: Abbott Laboratories: SWOT Analysis
Figure 15.7: B. Braun Melsungen AG.: Overall Product Portfolio
Figure 15.8: B. Braun Melsungen AG.: Overall Financials, 2017-2019
Figure 15.9: B. Braun Melsungen AG. Revenue (by Business Segment), 2017-2019
Figure 15.10: B. Braun Melsungen AG. Revenue (by Region), 2017-2019
Figure 15.11: B. Braun Melsungen AG.: R&D Expense, 2017-2019
Figure 15.12: B. Braun Melsungen AG: SWOT Analysis
Figure 15.13: Becton, Dickinson And Company: Overall Product Portfolio
Figure 15.14: Becton, Dickinson And Company: Overall Financials, 2017-2019
Figure 15.15: Becton, Dickinson and Company Revenue (by Business Segment), 2017-2019
Figure 15.16: Becton, Dickinson and Company Revenue (by Region), 2017-2019
Figure 15.17: Becton, Dickinson, and Company: R&D Expense, 2017-2019
Figure 15.18: Becton, Dickinson And Company: SWOT Analysis
Figure 15.19: Biotronik AG: Overall Product Portfolio
Figure 15.20: Biotronik AG: SWOT Analysis
Figure 15.21: Boston Scientific Corporation: Overall Product Portfolio
Figure 15.22: Boston Scientific Corporation: Overall Financials, 2017-2019
Figure 15.23: Boston Scientific Corporation Revenue (by Business Segment), 2017-2019
Figure 15.24: Boston Scientific Corporation Revenue (by Region), 2017-2019
Figure 15.25: Boston Scientific Corporation: R&D Expense, 2017-2019
Figure 15.26: Boston Scientific Corporation: SWOT Analysis
Figure 15.27: Cardinal Health, Inc.: Overall Product Portfolio
Figure 15.28: Cardinal Health, Inc.: Overall Financials, 2017-2019
Figure 15.29: Cardinal Health, Inc. Revenue (by Business Segment), 2017-2019
Figure 15.30: Cardinal Health, Inc. Revenue (by Region), 2017-2019
Figure 15.31: Cardinal Health, Inc.: SWOT Analysis
Figure 15.32: Cardionovum GmbH: Overall Product Portfolio
Figure 15.33: Cardionovum GmBH: SWOT Analysis
Figure 15.34: Concept Medical: Overall Product Portfolio
Figure 15.35: Concept Medical Inc: SWOT Analysis
Figure 15.36: Cook Group: Overall Product Portfolio
Figure 15.37: Cook Group: SWOT Analysis
Figure 15.38: Hexacath: Overall Product Portfolio
Figure 15.39: Hexacath: SWOT Analysis
Figure 15.40: Koninklijke Philips N.V.: Overall Product Portfolio
Figure 15.41: Koninklijke Philips N.V.: Overall Financials: 2017-2019
Figure 15.42: Koninklijke Philips N.V.: Revenue (by Business Segment), 2017-2019
Figure 15.43: Koninklijke Philips N.V.: Revenue (by Region), 2017-2019
Figure 15.44: Koninklijke Philips N.V: R&D Expense, 2017-2019
Figure 15.45: Koninklijke Philips N.V.: SWOT Analysis
Figure 15.46: Medtronic plc: Overall Product Portfolio
Figure 15.47: Medtronic plc: Overall Financials, 2017-2019
Figure 15.48: Medtronic plc: Revenue (by Segment), 2017-2019
Figure 15.49: Medtronic plc: Revenue (by Region), 2017-2019
Figure 15.50: Medtronic plc: R&D Expense, 2017-2019
Figure 15.51: Medtronic plc: SWOT Analysis
Figure 15.52: MicroPort Scientific Corporation: Overall Product Portfolio
Figure 15.53: MicroPort Scientific Corporation: Overall Financials, 2017-2019
Figure 15.54: MicroPort Scientific Corporation Revenue (by Business Segment), 2017
Figure 15.55: MicroPort Scientific Corporation Net Revenue (by Business Segment), 2018-2019
Figure 15.56: MicroPort Scientific Corporation Revenue (by Region), 2017-2019
Figure 15.57: MicroPort Scientific Corporation: R&D Expense, 2017-2019
Figure 15.58: MicroPort Scientific Corporation: SWOT Analysis
Figure 15.59: OrbusNeich Medical: Overall Product Portfolio
Figure 15.60: OrbusNeich Medical.: SWOT Analysis
Figure 15.61: Terumo Corporation: Overall Product Portfolio
Figure 15.62: Terumo Corporation: Overall Financials, 2017-2019
Figure 15.63: Terumo Corporation Revenue (by Business Segment), 2017-2019
Figure 15.64: Terumo Corporation Revenue (by Region), 2017-2019
Figure 15.65: Terumo Corporation.: R&D Expense, 2017-2019
Figure 15.66: Terumo Corporation: SWOT Analysis

Note: Product cover images may vary from those shown

Loading
LOADING...

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Biotronik AG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Cook Group
  • Hexacath
  • Koninklijke Philips N.V.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • OrbusNeich Medical
  • Terumo Corporation
Note: Product cover images may vary from those shown
Adroll
adroll